End-to-end sterility assurance with the new SCHOTT iQ® Integribag
Download the whitepaper to learn more about end-to-end sterility assurance during fill-and-finish!
Ready-to-use (RTU) drug delivery and containment solutions eliminate the need for pharma companies to wash and sterilize their containers before filling. Hence, it provides peace of mind and allows pharma companies to focus on their core competency of developing and manufacturing drugs. However, uncontrolled process steps, such as handling and transporting RTU containers to ISO 5 (Grade A) cleanroom zones, pose a contamination risk and can be challenging to manage. To reduce the risk of contamination and human errors, interest is growing in the continuous improvement of fill-and-finish processes and the preceding transfer steps into the aseptic zone.
Read the whitepaper to learn more about end-to-end sterility assurance with the new SCHOTT iQ® Integribag!
The whitepaper was initially published in Medicine Maker in June 2022.
Ready-to-use (RTU) drug delivery and containment solutions eliminate the need for pharma companies to wash and sterilize their containers before filling. Hence, it provides peace of mind and allows pharma companies to focus on their core competency of developing and manufacturing drugs. However, uncontrolled process steps, such as handling and transporting RTU containers to ISO 5 (Grade A) cleanroom zones, pose a contamination risk and can be challenging to manage. To reduce the risk of contamination and human errors, interest is growing in the continuous improvement of fill-and-finish processes and the preceding transfer steps into the aseptic zone.
Read the whitepaper to learn more about end-to-end sterility assurance with the new SCHOTT iQ® Integribag!
The whitepaper was initially published in Medicine Maker in June 2022.
